This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

This study has been completed.
Sponsor:
Information provided by:
St. Petersburg State Pavlov Medical University
ClinicalTrials.gov Identifier:
NCT00241995
First received: October 17, 2005
Last updated: October 17, 2006
Last verified: October 2005
  Purpose
The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Condition Intervention
Topiramate Lamotrigine Memnatine Diazepam Placebo Drug: Anticonvulsants

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment

Further study details as provided by St. Petersburg State Pavlov Medical University:

  Eligibility

Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Alcohol dependence Alcohol withdrawal syndrome

Exclusion Criteria:

Drug dependence Major psychiatric diagnoses Severe somatic illness

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00241995

Sponsors and Collaborators
St. Petersburg State Pavlov Medical University
Investigators
Principal Investigator: Evgeny M Krupitsky, MD, PhD St. Petersburg State Pavlov Medical University
  More Information

ClinicalTrials.gov Identifier: NCT00241995     History of Changes
Other Study ID Numbers: RCT-RCT_LOND_GAT_AWS_2003
Study First Received: October 17, 2005
Last Updated: October 17, 2006

Additional relevant MeSH terms:
Anticonvulsants

ClinicalTrials.gov processed this record on June 23, 2017